Description
This funding opportunity will catalyze discovery in digital health, advance pivotal research, and inform applications or interventions relevant to CIHR-IMHA's broad mandate areas. This funding opportunity also seeks to benefit the continued integration of technology into healthcare in Canada. These grants are reserved for early and mid-career researchers, and Indigenous Health researchers at any career stage. Patient and/or community engagement as an essential evaluation criterion for these grants, and inclusion of a Knowledge User or Patient Partner as a Principal Applicant or Co-applicant aligns with the Knowledge to Action Framework.
The CIHR-IMHA mandate includes: active living, mobility and the wide range of conditions related to bones, joints, muscles, connective tissue, skin as well as the mouth, teeth and craniofacial region. Digital health research that pertains to these research areas under the CIHR-IMHA mandate includes: SMART devices, wearables, internet of things, remote patient monitoring, clinical application of machine learning, virtual appointments, and addressing the health needs of those who live in remote and rural areas, including the northern regions, particularly given the known geographical health disparities in Canada. The development and scale-up of these tools and services has the potential to address well-established gaps in provision of care and can enhance access to, and efficiency of, healthcare services; strengthen patient-centered care including through greater health literacy relating to personal health data; and better mobilize knowledge between and among researchers, healthcare providers, patients and other knowledge users.
This funding opportunity supports the CIHR 2021-31 Strategic Plan Priority E: Integrate Evidence in Health Decisions, as a research investment that could support the mobilization of health system innovations including in technology, virtual care and artificial intelligence, and aligns with all three of the strategies under this priority. To support CIHR's Strategic Plan, CIHR-IMHA's will invest in digital health research that has the potential for immediate-to-medium term health impact (2-10 years). CIHR-IMHA is also committed to maintaining a focus on equity issues in this research area, specifically the assumption that clinical digital health (telehealth services) improves access.
CIHR and CIHR-IMHA support a research environment that reflects the principles of equity, diversity and inclusion (EDI). We are committed to reconciliation by strengthening the health and well-being of First Nations, Inuit and Métis Peoples. Achieving a more equitable, diverse, and inclusive Canadian research enterprise is essential in creating the excellent, innovative, and impactful research necessary to advance knowledge and understanding, and to respond to local, national, and global challenges. Beyond efforts to bolster EDI, CIHR recognizes that First Nations, Métis, and Inuit are rights-holding as First Peoples of Canada, and initiatives should be developed through distinctions-based approaches, as found in the CIHR strategic plan Setting new directions to support Indigenous research and research training in Canada 2019-2022. Applicants are required to ensure equitable access of diverse researchers, including First Nations, Inuit and Métis, to opportunities available within the research teams that will be established with program funding. This includes ensuring the research environment is supportive and any systemic barriers are addressed effectively and swiftly (see the Best Practices in Equity, Diversity and Inclusion in Research for guidance and examples of systemic barriers).
Role and Contributions of Applicant Partners: CIHR recognizes that a broad range of partners may be relevant to this opportunity and it is expected that applicant(s) describe the role of all applicant partners and how/if they will contribute to research and research related activities. Any consideration of risk and/or conflict of interest should also be explained, as appropriate.
Funds Available
CIHR and partner(s) financial contributions are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or decrease due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.
For more information on the appropriate use of funds, refer to Allowable Costs.
Objectives
The specific objectives of this funding opportunity are to:
CIHR reviewers heavily weight methodological rigor, including:
Strong theoretical framework
Clear hypotheses or research questions
Robust study design
Adequate controls, power calculations, and statistics
Reproducibility & transparency practices
Clear milestones and contingency plans
Predictor: Methodological strength is the #1 determinant across all CIHR committees.
CIHR prioritizes research that benefits:
The health of people living in Canada
Canadian healthcare systems and policies
Vulnerable or underserved populations
Chronic disease burdens in Canadian demographics
Predictor: Clear articulation of Canadian relevance dramatically improves scores.
Successful CIHR proposals:
Have 2–3 well-defined aims
Present realistic deliverables within the grant period
Include detailed methodologies for each aim
Avoid overambitious or unfocused scope
Demonstrate precise timeline and project management
Predictor: Feasibility + clarity of approach = high reviewer confidence.
Reviewers value:
Publications relevant to the field
Prior successful funding
Expertise aligned to each aim
Multi-disciplinary teams (clinicians, statisticians, biomedical scientists, policy experts)
For early-career investigators: mentorship, protected time, and institutional support
Predictor: A well-matched, credible team is essential.
Highly competitive CIHR proposals commonly include:
Pilot experiments or feasibility data
Retrospective analyses
Early mechanistic insights
Proof-of-concept findings
For high-risk or exploratory programs, strong rationale can substitute, but evidence is still preferred.
Predictor: Preliminary data significantly boosts chances.
CIHR explicitly evaluates EDI in:
Team composition
Training environment
Research design (sex, gender, intersectionality, inclusive sampling)
Barriers to participation or recruitment
Engagement with under-represented or Indigenous populations
Predictor: Meaningful EDI integration is essential; weak EDI sections lower scores.
CIHR places high value on:
How findings will reach clinicians, policymakers, communities, or the public
Realistic KT activities (briefs, publications, engagement, partnerships)
Integrated knowledge translation when applicable (co-design with stakeholders)
Predictor: Strong KT plan with defined stakeholders and products.
High success when aligned with:
Indigenous health
Digital health & AI
Aging and dementia
Chronic disease (cancer, cardiovascular, neurological)
Rare disease
Implementation science
Mental health, substance use
Health system strengthening
Predictor: Direct strategic alignment increases competitiveness.
CIHR reviewers look for feasibility evidence:
Confirmed clinical recruitment sites
Existing cohort or biobank access
Computational / lab infrastructure
Letters of support verifying data access
Agreements for collaboration or sharing
Predictor: Proven resource availability reduces perceived risk.
Successful budgets:
Are lean and proportional to aims
Avoid unnecessary equipment or inflated salaries
Align with Canadian Tri-Council rules
Include justification for trainees, supplies, analyses
Predictor: A clear, efficient budget strengthens feasibility.
| Pitfall | Why It Hurts |
|---|---|
| Vague or overly ambitious aims | Feasibility concerns |
| Weak or missing preliminary data | Too speculative |
| Poor methodology or unclear analytic plan | Low rigor |
| Minimal relevance to Canadian health | Weak significance |
| Poor EDI integration | Fails mandatory criteria |
| No KT or weak dissemination plan | Low potential impact |
| Unclear roles of team members | Execution risk |
| Overinflated budget | Reviewer concerns |
Eligibility to Apply
For an application to be eligible, all the requirements stated below must be met:
A NPA can submit a maximum of one (1) application under this funding opportunity. If the NPA submits more than one (1) application, CIHR will automatically withdraw the last application(s) submitted based on time-stamp of submission.
Note: NPAs applying as an ECR or MCR can identify participants (Principal Applicants and/or Co-Applicants) at other levels of seniority (ECRs, MCRs, Senior Researchers).
Sponsor Institute/Organizations: Canadian Institutes of Health Research
Sponsor Type: Corporate/Non-Profit
Address: 234 Laurier Ave West, Ottawa, ON K1A 0K9
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 17, 2026
Mar 17, 2026
$73,000
Affiliation: Canadian Institutes of Health Research
Address: 234 Laurier Ave West, Ottawa, ON K1A 0K9
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.